Hyperglucagonemia and insulin-mediated glucose metabolism

S. Del Prato, P. Castellino, D. C. Simonson, Ralph A Defronzo

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

The effect of chronic physiologic hyperglucagonemia on basal and insulin-mediated glucose metabolism was evaluated in normal subjects, using the euglycemic insulin clamp technique (+50, +100, and +500 μU/ml). After glucagon infusion fasting glucose increased from 76 ± 4 to 93 ± 2 mg/dl and hepatic glucose production (HGP) rose from 1.96 ± 0.08 to 2.25 ± 0.08 mg/kg·min (P < 0.001). Basal glucose oxidation after glucagon increased (P < 0.05) and correlated inversely with decreased free fatty acid concentrations (r = -0.94; P < 0.01) and decreased lipid oxidation (r = 0.75; P < 0.01). Suppression of HGP and stimulation of total glucose disposal were impaired at each insulin step after glucagon (P < 0.05-0.01). The reduction in insulin-mediated glucose uptake was entirely due to diminished non-oxidative glucose utilization. Glucagon infusion also caused a decrease in basal lipid oxidation and an enhanced ability of insulin to inhibit lipid oxidation and augment lipid synthesis. These results suggest that hyperglucagonemia may contribute to the disturbances in glucose and lipid metabolism in some diabetic patients.

Original languageEnglish (US)
Pages (from-to)547-556
Number of pages10
JournalJournal of Clinical Investigation
Volume79
Issue number2
StatePublished - 1987
Externally publishedYes

Fingerprint

Insulin
Glucose
Glucagon
Lipids
Aptitude
Glucose Clamp Technique
Liver
Lipid Metabolism
Nonesterified Fatty Acids
Fasting

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Del Prato, S., Castellino, P., Simonson, D. C., & Defronzo, R. A. (1987). Hyperglucagonemia and insulin-mediated glucose metabolism. Journal of Clinical Investigation, 79(2), 547-556.

Hyperglucagonemia and insulin-mediated glucose metabolism. / Del Prato, S.; Castellino, P.; Simonson, D. C.; Defronzo, Ralph A.

In: Journal of Clinical Investigation, Vol. 79, No. 2, 1987, p. 547-556.

Research output: Contribution to journalArticle

Del Prato, S, Castellino, P, Simonson, DC & Defronzo, RA 1987, 'Hyperglucagonemia and insulin-mediated glucose metabolism', Journal of Clinical Investigation, vol. 79, no. 2, pp. 547-556.
Del Prato, S. ; Castellino, P. ; Simonson, D. C. ; Defronzo, Ralph A. / Hyperglucagonemia and insulin-mediated glucose metabolism. In: Journal of Clinical Investigation. 1987 ; Vol. 79, No. 2. pp. 547-556.
@article{db5a7681cb20438aa63def9cbc1e1401,
title = "Hyperglucagonemia and insulin-mediated glucose metabolism",
abstract = "The effect of chronic physiologic hyperglucagonemia on basal and insulin-mediated glucose metabolism was evaluated in normal subjects, using the euglycemic insulin clamp technique (+50, +100, and +500 μU/ml). After glucagon infusion fasting glucose increased from 76 ± 4 to 93 ± 2 mg/dl and hepatic glucose production (HGP) rose from 1.96 ± 0.08 to 2.25 ± 0.08 mg/kg·min (P < 0.001). Basal glucose oxidation after glucagon increased (P < 0.05) and correlated inversely with decreased free fatty acid concentrations (r = -0.94; P < 0.01) and decreased lipid oxidation (r = 0.75; P < 0.01). Suppression of HGP and stimulation of total glucose disposal were impaired at each insulin step after glucagon (P < 0.05-0.01). The reduction in insulin-mediated glucose uptake was entirely due to diminished non-oxidative glucose utilization. Glucagon infusion also caused a decrease in basal lipid oxidation and an enhanced ability of insulin to inhibit lipid oxidation and augment lipid synthesis. These results suggest that hyperglucagonemia may contribute to the disturbances in glucose and lipid metabolism in some diabetic patients.",
author = "{Del Prato}, S. and P. Castellino and Simonson, {D. C.} and Defronzo, {Ralph A}",
year = "1987",
language = "English (US)",
volume = "79",
pages = "547--556",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Hyperglucagonemia and insulin-mediated glucose metabolism

AU - Del Prato, S.

AU - Castellino, P.

AU - Simonson, D. C.

AU - Defronzo, Ralph A

PY - 1987

Y1 - 1987

N2 - The effect of chronic physiologic hyperglucagonemia on basal and insulin-mediated glucose metabolism was evaluated in normal subjects, using the euglycemic insulin clamp technique (+50, +100, and +500 μU/ml). After glucagon infusion fasting glucose increased from 76 ± 4 to 93 ± 2 mg/dl and hepatic glucose production (HGP) rose from 1.96 ± 0.08 to 2.25 ± 0.08 mg/kg·min (P < 0.001). Basal glucose oxidation after glucagon increased (P < 0.05) and correlated inversely with decreased free fatty acid concentrations (r = -0.94; P < 0.01) and decreased lipid oxidation (r = 0.75; P < 0.01). Suppression of HGP and stimulation of total glucose disposal were impaired at each insulin step after glucagon (P < 0.05-0.01). The reduction in insulin-mediated glucose uptake was entirely due to diminished non-oxidative glucose utilization. Glucagon infusion also caused a decrease in basal lipid oxidation and an enhanced ability of insulin to inhibit lipid oxidation and augment lipid synthesis. These results suggest that hyperglucagonemia may contribute to the disturbances in glucose and lipid metabolism in some diabetic patients.

AB - The effect of chronic physiologic hyperglucagonemia on basal and insulin-mediated glucose metabolism was evaluated in normal subjects, using the euglycemic insulin clamp technique (+50, +100, and +500 μU/ml). After glucagon infusion fasting glucose increased from 76 ± 4 to 93 ± 2 mg/dl and hepatic glucose production (HGP) rose from 1.96 ± 0.08 to 2.25 ± 0.08 mg/kg·min (P < 0.001). Basal glucose oxidation after glucagon increased (P < 0.05) and correlated inversely with decreased free fatty acid concentrations (r = -0.94; P < 0.01) and decreased lipid oxidation (r = 0.75; P < 0.01). Suppression of HGP and stimulation of total glucose disposal were impaired at each insulin step after glucagon (P < 0.05-0.01). The reduction in insulin-mediated glucose uptake was entirely due to diminished non-oxidative glucose utilization. Glucagon infusion also caused a decrease in basal lipid oxidation and an enhanced ability of insulin to inhibit lipid oxidation and augment lipid synthesis. These results suggest that hyperglucagonemia may contribute to the disturbances in glucose and lipid metabolism in some diabetic patients.

UR - http://www.scopus.com/inward/record.url?scp=0023106636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023106636&partnerID=8YFLogxK

M3 - Article

VL - 79

SP - 547

EP - 556

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -